Northern Science Consulting Inc.

ノーザンサイエンスコンサルティング株式会社

お問い合わせ


ADMET 物性予測・メディシナルケミストリーソフトウエア

開発元:

ADMET Predictor® は、化合物構造から ADMET 物性を高速・高精度に予測します。第三者による数多くの論文で最も精度が高いとの評価を得ています。また、ユーザーデータに基づく独自の予測モデルを構築するモジュールも準備されており、in silico 初心者からエキスパートまで幅広くご利用いただけます。

新バージョン ADMET Predictor® 11 がリリースされました(Windows 版: 2023年7月18日、Linux 版: 7月20日)。

  ADMET Predictor 製品資料
Selected References

ADMET Predictor® が用いられている代表的な文献を以下にリストしています。


| 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2003 |

2017

Discovery of N-(pyridin-4-yl)-1,5-naphthyridin-2-amines as potential tau pathology PET tracers for Alzheimer's Disease.
Rombouts FJ, Andrés JI, Ariza M, Alonso JM, Austin N, Bottelbergs A, Chen L, Chupakhin V, Cleiren E, Fierens K, Fontana A, Langlois X, Leenaerts JE, Mariën J, Martínez Lamenca C, Salter R, Schmidt ME, Te Riele P, Wintmolders C, Trabanco AA, Zhang W, Macdonald G, Moechars D
J Med Chem. 2017 Feb 23;60(4):1272-1291.
Identification of novel TACE inhibitors compatible with topical application.
Gilles Ouvry, Yaël Berton, Yushma Bhurruth-Alcor, Laetitia Bonnary, Claire Bouix-Peter, Karine Bouquet, Marilyne Bourotte, Sandrine Chambon, Catherine Comino, Benoît Deprez, Denis Duvert, Gwenaëlle Duvert, Feriel Hacini-Rachinel, Craig S. Harris, Anne-Pascale Luzy, Arnaud Mathieu, Corinne Millois, Jonathan Pascau, Laurent F. Hennequin
Bioorganic & Medicinal Chemistry Letters. Volume 27, Issue 8, 15 April 2017, Pages 1848-1853
Identification, characterization and in silico ADMET prediction of Roflumilast degradation products.
Mariana S. Pinheiro, Gil M. Viana, Bárbara de A. Abrahim Vieira, Alessandra Mendonça Teles de Souza, Carlos Rangel Rodrigues, Rita de Cássia E.E. Marins, Lúcio M. Cabral, Valéria P. de Sousa
Journal of Pharmaceutical and Biomedical Analysis. Volume 138, 10 May 2017, Pages 126-133
Synthesis, antioxidant, antifungal, molecular docking and ADMET studies of some thiazolyl hydrazones.
Sushama Kauthale, Sunil Tekale, Manoj Damale, Jaiprakash Sangshetti, Rajendra Pawar
Bioorganic & Medicinal Chemistry Letters. Volume 27, Issue 16, 15 August 2017, Pages 3891-3896
In silico prediction of skin metabolism and its implication in toxicity assessment.
J.C. Madden, S. Webb b, S.J. Enoch, H.E. Colley, C. Murdoch, R. Shipley, P. Sharma, C. Yang, M.T.D. Cronin
Computational Toxicology. Volume 3, August 2017, Pages 44-57
Identification of impurities in macrolides by liquid chromatography–mass spectrometric detection and prediction of retention times of impurities by constructing quantitative structure–retention relationship (QSRR).
Xia Zhang, Jin Li, Chen Wang, Danqing Song, Changqin Hu
Journal of Pharmaceutical and Biomedical Analysis. Volume 145, 25 October 2017, Pages 262-272
Synthesis and pharmacodynamics of ibuprofen-1-acetoxyethyl ester.
Bowei Wang, Wanshi Hou, Yingnan Wang, Shaoheng Li, Zhihui Liu, Zhiguang Song
Chemical Research in Chinese Universities. August 2017, Volume 33, Issue 4, pp 569–573
An Intuitive Approach for Predicting Potential Human Health Risk with the Tox21 10k Library.
Nisha S. Sipes, John F. Wambaugh, Robert Pearce, Scott S. Auerbach, Barbara A. Wetmore, Jui-Hua Hsieh, Andrew J. Shapiro, Daniel Svoboda, Michael J. DeVito, Stephen S. Ferguson
Environ. Sci. Technol., 2017, 51 (18), pp 10786–10796
The Use of In Vitro and In Silico Technologies for Predicting Human Pharmacology and Toxicology of Carfentanil.
Feasel M G (2017)
ProQuest Dissertations Publishing,2017.
Prediction of intracellular exposure bridges the gap between target- and cell-based drug discovery.
Mateus A, Gordon LJ, Wayne GJ, Almqvist H, Axelsson H, Seashore-Ludlow B, Treyer A, Matsson P, Lundbäck T, West A, Hann MM, Artursson P
Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):E6231-E6239.
Structural and conformational determinants of macrocycle cell permeability.
Over B, Matsson P, Tyrchan C, Artursson P, Doak BC, Foley MA, Hilgendorf C, Johnston SE, Lee MD 4th, Lewis RJ, McCarren P, Muncipinto G, Norinder U, Perry MW, Duvall JR, Kihlberg J
Nat Chem Biol. 2016 Dec;12(12):1065-1074.
Substrate and method dependent inhibition of three ABC-transporters (MDR1, BCRP, and MRP2).
Pedersen JM, Khan EK, Bergström CAS, Palm J, Hoogstraate J, Artursson P
Eur J Pharm Sci. 2017 May 30;103:70-76.

2016

Informing the Human Plasma Protein Binding of Environmental Chemicals by Machine Learning in the Pharmaceutical Space: Applicability Domain and Limits of Predictability
Ingle BL, Veber BC, Nichols JW, Tornero-Velez R. (2016)
J. Chem. Info. Model. online September 29.
Predicting ADME Properties of Chemicals.
Shin, HK, Kang, Y, No, KT. (2016)
In "Handbook of Computational Chemistry" ed. Jerzy Leszcznski, published by Springer Netherlands.
High throughput virtual screening and in silico ADMET analysis for rapid and efficient identification of potential PAP248-286 aggregation inhibitors as anti-HIV agents.
Malik R, Bunkar D, Choudhary BS, Srivastava S, Mehta P, Sharma M. (2016)
J. Mol. Struct., 1122, 239-246.
Pore blocking: An innovative formulation strategy for the design of alcohol resistant multi-particulate dosage forms.
Schrank S, Jedinger N, Wu S, Piller M, Roblegg E. (2016)
Int. J. Pharm. 509, 219-228.
Design, Synthesis, and Biological Evaluation of Novel PARP-1 Inhibitors Based on a 1H-Thieno[3,4-d] Imidazole-4-Carboxamide Scaffold.
Wang L, Liu F, Jiang N, Zhou W, Zhou X, Zheng Z. (2016)
Molecules , 21(6), 772.
Modeling ADMET.
Ghosh J, Lawless MS, Waldman M, Gombar V, Fraczkiewicz R. (2016)
In "In Silico Methods for Predicting Drug Toxicity, for the series Methods in Molecular Biology", ed. Emilio Benfenati, published by Springer New York.
In Silico Models for Acute Systemic Toxicity.
Burton J, Worth AP, Tsakovska I, Diukendjieva, A. (2016)
In "In Silico Methods for Predicting Drug Toxicity, for the series Methods in Molecular Biology", ed. Emilio Benfenati, published by Springer New York.
In Silico Prediction of Chemically Induced Mutagenicity: How to Use QSAR Models and Interpret Their Results.
Mombelli E, Raitano G, Benfenati E. (2016)
In "In Silico Methods for Predicting Drug Toxicity, for the series Methods in Molecular Biology", ed. Emilio Benfenati, published by Springer New York.
Descriptors and their selection methods in QSAR analysis: paradigm for drug design.
Danishuddin, Khan AU. (2016)
Drug Discovery Today, July.
High-throughput virtual screening and quantum mechanics approach to develop imipramine analogues as leads against trypanothione reductase of leishmania.
Pandey RK, Verma P, Sharma D, Bhatt TK, Sundar S, Prajapati VK. (2016)
Biomedicine & Pharmacotherapy, 83, 141-152.
Evaluating the Impact of Uncertainties in Clearance and Exposure When Prioritizing Chemicals Screened in High-Throughput Assays.
Leonard JA , Leonard AS, Chang D, Edwards S, Lu J, Scholle S, Key P, Winter M, Isaacs KK, Tan YC. (2016)
Environ. Sci. Technol., online April 28.
Comparative human in-vivo study of an immediate release tablet over-encapsulated by gelatin and hydroxypropyl methyl cellulose capsules – impact of dissolution rate on bioequivalence.
Stegemann S, Vishwanath S, Kumar R, Cade D, Lowery M, Hutchison K, Michael Morgen M, Goodwin A, Lee C.(2016)
Capsugel white paper.
Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase.
Pandey RK, Kumbhar BV, Sundar S, Kunwar A, Prajapati VK. (2016)
J. Receptors and Signal Transduction.
Integration of Life-Stage Physiologically-Based Pharmacokinetic (PBPK) Models with Adverse Outcome Pathways (AOPs) and Environmental Exposure Models to Screen for Environmental Hazards.
El-Masri H, Kleinstreuer N, Hines RN, Adams L, Tal T, Isaacs K, Wetmore BA, Tan Y. (2016),
Tox. Sci., online May 4.
In silico screening of novel inhibitors of M17 Leucine Amino Peptidase (LAP) of Plasmodium vivax as therapeutic candidate.
Rout S, RK Mahapatra RK. (2016)
Biomedicine & Pharmacotherapy, 82, 192-201.
BDDCS, the Rule of 5 and drugability.
Benet LZ, Hosey CM, Ursu O, Oprea TI. (2016)
Adv. Drug Delivery Reviews, 101, 89-98.
Impact of curcumin on the pharmacokinetics of rosuvastatin in rats and dogs based on the conjugated metabolites.
Zhou X, Zhang F, Chen C, Guo Z, Liu J, Yu J, Xu Y, Zhong D, Jiang H. (2016)
Xenobiotica, online May 13.
Synthesis and Preclinical Evaluation of Sulfonamido based [11C-Carbonyl]-Carbamates and Ureas for Imaging Monoacylglycerol Lipase.
Wang L, Mori W, Cheng R, Yui J, Hatori A, Ma L, Zhang Y, Rotstein BH, Fujinaga M, Shimoda Y, Yamasaki T, Xie L, Nagai Y, Minamimoto T, Higuchi M, Vasdev N, Zhang M, Liang SH. (2016)
Theranositcs, 6(8), 1145-1159.
Development of In Vitro In Vivo Correlation Models For Clopidogrel Tablets To Describe Administration Under Fasting And Fed Conditions.
Savu SN, Silvestro L, Mirioiu C, Anuta V. (2016)
Farmacia, 64, 2.
Introduction to Cheminformatics.
Wishart DS. (2016)
Current Protocols in Bioinformatics, published online: March 24.
Quantitative structure-retention relationship of selected imidazoline derivatives on alpha1-acid glycoprotein column.
Filipic S, Ruzic D, Vucicevic J, Nikolic K, Agbaba D. (2016)
J. Pharm. Biomed. Analysis, online March 3.
Computational prediction of formulation strategies for beyond-rule-of-5 compounds.
Bergstrom CAS, Charman WN, Porter CJH. (2016)
Adv. Drug Delivery Reviews, online Feb. 27.
Novel nonquaternary reactivators showing reactivation efficiency for soman-inhibited human acetylcholinesterase.
Wei Z, Liu Y, Wang Y, Li W, Zhou X, Zhao X, Zhao J, Huang C, Li X, Liu J, Zheng Z, Li S. (2016)
Toxicology Letters, 246, 1-6.
Synthesis and Evaluation of Novel Radioligands Based on 3-[5-(Pyridin-2-yl)-2H-tetrazol-2-yl]benzonitrile for Positron Emission Tomography Imaging of Metabotropic Glutamate Receptor Subtype 5.
Shimoda Y, Yamasaki T, Fujinaga M, Ogawa M, Kurihara Y, Nengai N, Kumata K, Yui J, Hatori A, Xie L, Zhang Y, Kawamu K, Zhang M. (2016)
J. Med. Chem., 59 (8), 3980–3990.
Exploring dual inhibitory role of febrifugine analogues against Plasmodium utilizing structure-based virtual screening and molecular dynamic simulation.
Pandey RK, Narula A, Naskar M, Srivastava S, Verma P, Malik R, Shah P, Prajapatia VK. (2016)
J. Biomolecular Structure and Dynamics, published online: April 18.
In vitro and in vivo evaluations of the P-glycoprotein-mediated efflux of dibenzoylhydrazines.
Miyataa K, Nakagawa Y, Kimura Y, Ueda K, Akamatsua M. (2016)
Toxiclogy and Applied Pharmacology, 298, 40-47.
Novel S1P1 receptor agonists – Part 5: From amino-to alkoxy-pyridines.
Bolli MH, Lescop C, Birker M, de Kanter R, Hess P, Kohl C, Nayler O, Rey M, Sieber P, Velker J, Weller T, Steiner B. (2016)
Eur. J. Med. Chem., 115, 326-341.
Provenance of Computers in Pharmacy.
Bandameedi R. (2016)
Clin Pharmacol Biopharm, 5:153.
Pharmacokinetic evaluation of cefdinir-loaded floating alginate beads in rabbits using LC–MS/MS.
Praveen R, Singh SK, Ranjan P, Verma P. (2016)
J. Pharm. Invest. Online March 5.
Development of a Physiologically Based Pharmacokinetic/Pharmacodynamic Model to Predict the Impact of Genetic Polymorphisms on the Pharmacokinetics and Pharmacodynamics Represented by Receptor/Transporter Occupancy of Central Nervous System Drugs.
Alqahtani S, Kaddoumi A. (2016)
Clinical Pharmacokinetics, online February 25.
New design of nucleotide excision repair (NER) inihibitors for combination cancer therapy.
Gentile F, Tuszynskia JA, Barakat KH. (2016)
J. Mol. Graphics and Modeling, 65, 71-82.
Use of Modeling and Simulation Tools for Understanding the Impact of Formulation on the Absorption of a Low Solubility Compound: Ciprofloxacin.
Marilyn Martinez M, Mistry B, Lukacova V, Polli J, Hoag S, Dowling T, Kona R, Fahmy R.(2016)
AAPS J. Online April 26.
In vivo in silico pharmacokinetic simulation studies of carvedilol-loaded nanocapsules using GastroPlus™.
George JK, Singh SK, Verma PRP.(2016)
Therapeutic Delivery, 7(5), 305-318.
Characterizing the Dissolution Profiles of Supersaturable Salts, Cocrystals, and Solvates to Enhance In Vivo Oral Absorption.
Hisada N, Takano R, Takata N, Shiraki K, Ueto T, Tanida S, Kataoka M, Yamashita S.(2016)
Eur J Pharm Biopharm. Online April 7.
Software and Web Resources for Computer-Aided Molecular Modeling and Drug Discovery.
Yadav DK, Rai R, Pratap R, Singh H.(2016)
Chemometrics Applications and Research: QSAR in Medicinal Chemistry, ed. By Andrew G. Mercader, Pablo R. Duchowicz, and PM Sivakumar.
Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage.
Miyaji Y, Fujii Y, Takeyama S, Kawai Y, Kataoka, M‡, Takahashi M, Yamashita S.(2016)
Mol. Pharmaceutics, 13 (5), pp 1564–1574.
Identification of Novel Potential Inhibitors of Aldose Reductase: A Multistage Computational Filtering Approach.
Joseph JM, Kesherwani M, Velmurugan D. (2016)
Recent Advance in Diabetes Treatment, Avid Science, ebook.
Physiologically Based Absorption Modeling to Impact Biopharmaceutics and Formulation Strategies in Drug Development—Industry Case Studies.
Kesisoglou F, Chung J, van Asperen J, Heimbach T. (2016)
J. Pharmaceutical Sciences, online 23 Jan.
LC-ESI-MS/MS estimation of loratadine-loaded self-nanoemulsifying drug delivery systems in rat plasma: Pharmacokinetic evaluation and computer simulations by GastroPlus™.
Verma S, Singh SK. (2016)
Journal of Pharmaceutical and Biomedical Analysis, 124, 10-21.
Estimating Margin of Exposure to Thyroid Peroxidase Inhibitors Using High-throughput In Vitro Data, High-throughput Exposure Modeling, and Physiologically-Based Pharmacokinetic/Pharmacodynamic Modeling.
Leonard JA, Tan Y, Gilbert M, Isaacs K, El-Masri, H. (2016)
Toxicological Sciences, 151, 57-70.
Design and synthesis of some new 1-phenyl-3/4-[4-(aryl/heteroaryl/alkyl-piperazine1-yl)-phenyl-ureas as potent anticonvulsant and antidepressant agents.
Mishra CB, Kumari S, Tiwar M. (2016)
Archives of Pharmacal Research, online February 18.
Acute Toxicity Tests: Tools for Assessment of Toxicological Effects of Plants.
Balogun ST, Sandabe UK, Jibrin J, Ibrahim E, Fehintola FA. (2016)
International Journal of Indigenous Medicinal Plants, ISSN: 2051-4263, Vol.48, Issue 1.
Predicting biopharmaceutical performance of oral drug candidates–Extending the Volume to Dissolve Applied Dose concept
Muenster U, Mueck W, van der Mey D, Schlemmer K, Greschat-Schade S, Haerter M, Pelzetter C, Pruemper C, Verlage J, Goeller AH, Ohm A. (2016)
Euro. J. Pharm. And Biopharm., available online March 5.
Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-Oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis.
Karabanovich G, Zemanová J, Smutný T, Székely R, Šarkan M, Centárová I, Vocat A, Pávková I, Conka P, Nemecek J, Stolaríková J, Vejsová M, Vavrova K, Klimešová V, Hrabalek A, Pavek P, Cole ST, Mikušová K, and Roh J. (2016)
J. Med. Chem. web pub. Date March 5.
Radiosynthesis and evaluation of N-(3,4-dimethylisoxazol-5-yl)piperazine-4-[4-(4-fluorophenyl)thiazol-2-yl]-1-[11C]carboxamide for in vivo positron emission tomography imaging of fatty acid amide hydrolase in brain.
Shimoda Y, Yui Y, Zhang Y, Hatori A, Ogawa M, Fujinaga M, Yamasaki T, Xie L, Kumata K, Zhang MR. (2015)
RSC Adv., 5, 106122-106127.
Chromatographic lipophilicity as a predictor of antiproliferative activity of 17-picolyl and 17-picolinylidene androstane derivatives toward prostate cancer.
Kovacevic SZ, Podunavac-Kuzmanovic SO, Jevric LR, Djurendic EA, Ajdukovic JJ, Jovanov PT. (2015)
APTEFF, 46, 1-269.
Evaluations of imidazolium ionic liquids as novel skin permeation enhancers for drug transdermal delivery.
Zhang D, Wang H, Cui X, Wang C. (2016)
Pharmaceutical Development and Technology, published online Jan 13.
Discovery of novel S1P 2 antagonists, part 3: Improving the oral bioavailability of a series of 1, 3-bis (aryloxy) benzene derivatives.
Kusumia K, Shinozakib K, Yamauraa Y, Hashimotoa A, Kurataa H, Naganawaa A, Otsukia K, Matsushitaa T, Sekiguchia T, Kakuuchia A, Yamamoto H, Seko T. (2016)
Bioorg. & Med. Chem. Lett., 26(4), 1209-1213.
Ferulic acid-carbazole hybrid compounds: combination of cholinesterase inhibition, antioxidant and neuroprotection as multifunctional anti-Alzheimer agents.
Fang L, Chen M, Liu Z, Fang X, Gou S, Chen L. (2016)
Bioorg. & Med. Chem. Lett., 24(4), 886-893.
Febrifugine analogues as Leishmania donovani trypanothione reductase inhibitors: binding energy analysis assisted by molecular docking, ADMET and molecular dynamics simulation.
Pandey RK, Kumbhar BV, Srivastava S, Malik R, Sundar S, Kunwar A, Prajapati VK. (2016)
Journal of Biomolecular Structure and Dynamics, online 3 Jan.
A Study on in-silico Analysis of Phytochemicals targeting the proteins of Hepatitis B and C Virus.
Vani GS and Rajarajan S. (2015)
Int.J.Curr.Microbiol.App.Sci 4(12): 683-691.
Development of a unified dissolution and precipitation model and its use for the prediction of oral drug absorption.
Jakubiak P, Wagner B, Grimm HP, Petrig-Schaffland J, Schuler F, and Alvarez-Sanchez R. (2016)
Mol. Pharm., 13(2), 586-598.
N-(3, 4-Dimethylisoxazol-5-yl) piperazine-4-[4-(2-fluoro-4-[11C] methylphenyl) thiazol-2-yl]-1-carboxamide: a promising positron emission tomography ligand for fatty acid amide hydrolase.
Shimoda Y, Fujinaga M, Hatori A, Yui J, Zhang Y, Nengaki N, Kurihara Y, Yamasaki T,Xie L, Kumata K, Ishiia H, Zhang M. (2016)
Bioorg. & Med. Chem., 24(4), 627-634.

2015

Tales from the war on error: the art and science of curating QSAR data.
Waldman M, Fraczkiewicz R, and Clark RD. (2015) J Comput Aided Mol Des.
29(9), 897-910.
Discovery of new acetylcholinesterase inhibitors with small core structures through shape-based virtual screening
Chen Y, Liu Z, Fu T, Li W, Xu X, Sun H.
Bioorg. & Med. Chem. Lett., 2015, 25, 3442-3446.
Assessment of in silico models for acute aquatic toxicity towards fish under REACH regulation.
Cappelli CI, Cassano A, Golbamaki A, Lombardo A,Colafranceschi M, Benfenati E.
SAR and QSAR in Environmental Research, online Nov. 2015.
Benzazaborinines as novel bioisosteric replacements of naphthalene: propranolol as an example.
Rombouts FJR, Tovar F, Austin N, Tresadern G, Trabanco AA. J. Med.
Chem., Just Accepted Manuscript, Nov. 13, 2015.
Pharmacologic Activities of 3'-Hydroxypterostilbene: Cytotoxic, Anti-Oxidant, Anti-Adipogenic, Anti-Inflammatory, Histone Deacetylase and Sirtuin 1 Inhibitory Activity.
Takemoto JK, Remsberg CM, Davies NM.
J. Pharm. Pharm. Sci 18(4) 713-727, 2015.
Analysis of Intra- and Intersubject Variability in Oral Drug Absorption in Human Bioequivalence Studies of 113 Generic Products.
Sugihara M, Takeuchi S, Sugita M, Higaki K, Kataoka M,Yamashita S. Mol.
Pharmaceutics, Article ASAP Nov. 15, 2015.
Tools for early prediction of drug loading in lipid-based formulations.
Alskar LC, Porter CJH, Bergstrom CAS.
Mol. Pharmaceuticals, web., Nov. 15, 2015.
A review of the current state of the art of physiologically-based tests for measuring human dermal in vitro bioavailability of polycyclic aromatic hydrocarbons (PAH) in soil.
Beriro DJ, Cave MR, Wragg J, Thomas R,Wills G, Evansc F.
J. Hazardous Materials, Available online 18 November 2015.
The use of computational chemistry to predict toxicity of antioxidants food additives and its metabolites as a reference for food safety regulation.
Damayanti S, Permana J, Tjahjono DH.
Der Pharma Chemica, 2015, 7(9):174-181.
Novel derivatives of nitro-substituted salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.
Paraskevopoulos G,Krátký M,Mandíková J, Trejtnar F, Stolaríková J, Pávek P,Besra G, Vinšová
J. Bioorg. and Med. Chem., Available online 24 October 2015.
In vitro anticancer properties and biological evaluation of novel natural alkaloid jerantinine B.
Qazzaz ME, Raja VJ, Lim K, Kam T, Lee JB, Gershkovich P, Bradshaw TD.
Cancer Letters, online Oct. 26, 2015.
The evolution and future of environmental partition coefficients.
Mackay D, Celsie AKD, Parnis JM.
Environmental Reviews, published on the web 04 November 2015.
Discovery of New Scaffolds from Approved Drugs as Acetylcholinesterase Inhibitors
Chen, Y, Xu X, Fu T, Li W, Liu Z, Sun H.
RSC Adv., 2015,5, 90288-90294.
Development of Physiologically Based Pharmacokinetic/Pharmacodynamic
Model for Indomethacin Disposition in Pregnancy.
S Alqahtani, A Kaddoumi , PLOS One, October 2015.
Role of computer-aided drug design in modern drug discovery.
Macalino, SJY, Gosu V, Hong S, and Choi S. (2015)
Archives of Pharmacal Research 38(9), 1686-1701.
Lipidic dispersion to reduce food dependent oral bioavailability of fenofibrate: in vitro, in vivo and in silico assessments
O’Shea JP, Faisal W, Ruane-O’Hora T, Devine, KJ, Kostewicz ES, O’Driscolla CM, and, Griffin BT (2015)
European J Pharmaceutics and Biopharmaceutics, 96, 207-216.
Development of a Physiologically Based Pharmacokinetic/Pharmacodynamic Model to Identify Mechanisms Contributing to Entacapone Low Bioavailability.
Alqahtani S and Kaddoumi A. (2015)
Biopharmaceutics & Drug Disposition, accepted online.
Homology Modeling, Molecular Dynamic Simulation and In Silico Screening of Activator for the Intensification of Human Sirtuin Type 1 (SIRT1) By Novel 1, 3, 4-Thiadiazole Derivatives-A Potential Antiaging Approach.
Saha S, Rai A, and Raj V. (2015)
J Bioanal Biomed, Volume 7(4), 97-103.
Intestinal solubility and absorption of poorly water soluble compounds: predictions, challenges and solutions.
Fagerberg JH and Bergström CAS. (2015)
Therapeutic Delivery online August.
Using Cheminformatics in Drug Discovery.
Lawless MS, Waldman M, Fraczkiewicz R, and Clark RD. (2015)
Handbook of Experimental Pharmacology, Springer.
Identification of a major radiometabolite of [11C]PBB3.
Hashimotoa H, Kawamuraa K, Takeia M, Igarashia N, Fujishiroa T, Shiomia S, Watanabea R, Mutoa M, Furutsukaa K, Itoa T, Yamasakia T, Yuia J,Nemotoa K, Kimuraa Y, Higuchia M, and Zhanga M-R. (2015)
Nuclear Medicine and Biology, accepted online.
Physical Stability of Drugs after Storage Above and Below the Glass Transition Temperature: Relationship to Glass-Forming Ability.
Alhalaweha A, Alzghoulb A, Mahlina D, and Bergström, CAS. (2015)
International Journal of Pharmaceuticals, 405(1), 312-317.
Marine Drug Discovery Database (MDDD) – A Database of In silico Predicted Physico-Chemical, Drug Likeness and Toxicological Properties of Marine Compounds.
Sripathy R, Vidya A, Balasubramanian V, Arokiaraj A, Ramchand CN, and Sundararaman M. (2015)
Journal of Advanced Bioinformatics Applications and Research, 6(2), 33-44.
Discovery of novel S1P2 antagonists. Part 2: Improving the profile of a series of 1,3-bis(aryloxy)benzene derivatives.
Kusumia K, Shinozakib K, Yamauraa Y, Hashimotoa A, Kurataa H, Naganawaa A, Uedac H, Otsukia K, Matsushitaa T, Sekiguchia T, Kakuuchia A, and Sekoc T. (2015)
Bioorg. Med. Chem. Letters online 8 Sept.
1,4-Oxazine beta-secretase (BACE1) inhibitors: from hit generation to orally bioavailable brain penetrant leads.
Rombouts FJR, Tresadern G, Delgado O, Lamenca CM, Van Gool M, García-Molina A, De Diego SAA, Oehlrich D, Prokopcova H, Alonso JM, Austin N, Borghys H, Van Brandt S, Surkyn M, De Cleyn M, Vos A, Alexander R, Macdonald GJ, Moechars D, Gijsen HJM, and Trabanco AA. (2015)
J. Med. Chem. just accepted.
Experimental and Computational Prediction of Glass Transition Temperature of Drugs
Alzghoul A,Alhalaweh A,Mahlin D, Bergstrom CAS.
J. Chem. Info. Model (2014), 54 (12), 3396-3403
Acute toxicity prediction in multiple species by leveraging mechanistic ToxCast mitochondrial inhibition data and simulation of oral bioavailability.
Bhhatarai B, Wilson DM, Bartels MJ, Chaudhuri S, Price PS, Carney EW. (2015)
Toxicol Sci. Jul 2.
QSAR studies and design of new analogs of vitamin E with enhanced antiproliferative activity on MCF-7 breast cancer cells
Gagic Z, Nikolic K, Ivkovic B, Filipic S, and Agbaba, D. (2015) J Taiwan
Inst Chem Eng August 20 online.
Effect of SI-591, a new class of cathepsin K inhibitor with peptidomimetic structure, on bone metabolism in vitro and in vivo
Fujii T, Ishikawa M, Kubo A, and Tanaka Y. (2015)
Bone August 20 online.
A Workflow to Investigate Exposure and Pharmacokinetic Influences on High-Throughput in Vitro Chemical Screening Based on Adverse Outcome Pathways.
Phillips MB, Leonard JA, Grulke CM, Chang DT, Edwards SW, Brooks R, Goldsmith MR, El-Masri H, Tan YM. (2015)
Environ Health Perspect. May 15.
An in silico expert system for the identification of eye irritants.
Verma RP, Matthews EJ. (2015)
SAR QSAR Environ Res. May;26(5):383-95.
In silico prediction of hERG inhibition.
Jing Y, Easter A, Peters D, Kim N, Enyedy IJ. (2015)
Future Med Chem. Apr;7(5):571-86.
In silico optimization of pharmacokinetic properties and receptor binding affinity simultaneously: a 'parallel progression approach to drug design' applied to ß-blockers.
Advani P, Joseph B, Ambre P, Pissurlenkar R, Khedkar V, Iyer K, Gabhe S, Iyer RP, Coutinho E. (2015)
J Biomol Struct Dyn. May 20:1-15.
Predicting the extent of metabolism using in vitro permeability rate measurements and in silico permeability rate predictions.
Hosey CM, Benet LZ. (2015)
Mol Pharm. May 4;12(5):1456-66.
5-Aryl-1H-pyrazole-3-carboxylic acids as selective inhibitors of human carbonic anhydrases IX and XII.
Cvijetic IN, Tançb M, Juranicc IO, Verbicd TZ, Supuranb CT, Drakulicc BJ. (2015)
Bioorganic & Med. Chem. June 4
Freezing the Bioactive Conformation to Boost Potency: The Identification of BAY 85-8501, a Selective and Potent Inhibitor of Human Neutrophil Elastase for Pulmonary Diseases.
von Nussbaum F, Li VM, Allerheiligen S, Anlauf S, Bärfacker L, Bechem M, Delbeck M, Fitzgerald MF, Gerisch M, Gielen-Haertwig H, Haning H, Karthaus D, Lang D, Lustig K, Meibom D, Mittendorf J, Rosentreter U, Schäfer M, Schäfer S, Schamberger J, Telan LA, Tersteegen A. (2015)
ChemMedChem. Jul;10(7):1163-73
Liver-selective distribution in rats supports the importance of active uptake into the liver via organic anion transporting polypeptides (OATPs) in humans.
Mikkaichi T, Nakai D, Yoshigae Y, Imaoka T, Okudaira N, Izumi T. (2015)
Drug Metabolism and Pharmacokinetics June 24
Discovery of a Potent, Orally Available Dual CysLT1 and CysLT2 Antagonist with Dicarboxylic Acid.
Itadani S, Takahashi S, Ima M, Sekiguchi T, Aratani Y, Egashira H, Matsumura N, Inoue A, Yonetomi Y, Fujita M, Nakayama Y, Takeuchi J. (2015)
Bioorganic & Med. Chem. Mar 7
The importance of critical micellar concentration for the prediction of solubility enhancement in biorelevant media.
Ottaviani G, Wendelspiess S, Alvarez-Sanchez R. (2015)
Mol Pharm. Feb 9.
The influence of salt chaotropicity, column hydrophobicity and analytes’ molecular properties on the retention of pramipexole and its impurities.
Vemic A, Kalinic M, Eric S, Malenovica A, Medenicac M. (2015)
J. of Chromatography Feb. 1
Evaluation and comparison of benchmark QSAR models to predict a relevant REACH endpoint: The bioconcentration factor (BCF).
Gissi A, Lombardo A, Roncaglioni A, Gadaleta D, Mangiatordi GF, Nicolotti O, Benfenati E. (2015)
Environ Res. Jan 20;137C:398-409

Comparison of in silico tools for evaluating rat oral acute toxicity.
Diaza RG, Manganelli S, Esposito A, Roncaglioni A, Manganaro A, Benfenati E. (2015)
SAR QSAR Environ Res. Jan 8:1-27
Design, Synthesis and Pharmacological evaluation of N-[4-(4-(alkyl/aryl/heteroaryl/)-piperazin-1-yl)-phenyl]-carbamic acid ethyl ester derivatives as novel anticonvulsant agents.
Kumari S, Mishra CB, Tiwari M. (2015)
Bioorganic & Medicinal Chemistry Letters Jan. 9

Prediction of blood-brain barrier permeation of a-adrenergic and imidazoline receptor ligands using PAMPA technique and quantitative-structure permeability relationship analysis.
Vucicevic J, Nikolic K, Dobricic V, Agbaba D. (2015)
Eur J Pharm Sci. 68C:94-105

2014

Computational classification models for predicting the interaction of drugs with P-glycoprotein and breast cancer resistance protein.
Eric S, Kalinic M, Ilic K, Zloh M. (2014)
SAR QSAR Environ Res. 25(12):955-82
Targeting pharmacoresistant epilepsy and epileptogenesis with a dual-purpose antiepileptic drug.
Doeser A, Dickhof G, Reitze M, Uebachs M, Schaub C, Pires NM, Bonifácio MJ, Soares-da-Silva P, Beck H. (2014)
Brain. Dec 2.
Estimation of the chemical-induced eye injury using a weight-of-evidence (WoE) battery of 21 artificial neural network (ANN) c-QSAR models (QSAR-21): Part I: Irritation potential.
Verma RP, Matthews EJ. (2014)
Regul Toxicol Pharmacol. pii: S0273-2300(14)00286-4
Estimation of the chemical-induced eye injury using a Weight-of-Evidence (WoE) battery of 21 artificial neural network (ANN) c-QSAR models (QSAR-21): Part II: Corrosion potential.
Verma RP, Matthews EJ. (2014)
Regul Toxicol Pharmacol. pii: S0273-2300(14)00297-9
Isoxazolotacrines as non-toxic and selective butyrylcholinesterase inhibitors for Alzheimer's disease.
Cherif O, Allouche F, Chabchoub F, Chioua M, Soriano E, Yañez M, Cacabelos R, Romero A, López MG, Marco-Contelles J. (2014)
Future Med Chem. 6(17):1883-91.
Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study.
Su J, Chang C, Xiang Q, Zhou ZW, Luo R, Yang L, He ZX, Yang H, Li J, Bei Y, Xu J, Zhang M, Zhang Q, Su Z, Huang Y, Pang J, Zhou SF. (2014)
Drug Des Devel Ther. 8:2555-602.
Best of Both Worlds: Combining Pharma Data and State of the Art Modeling Technology to Improve in silico pKa Prediction.
Fraczkiewicz R, Lobell M, Göller AH, Krenz U, Schoenneis R, Clark RD, Hillisch A. (2014)
J. Chem. Inf. Model. (Just Accepted Manuscript)
Formulation of the Microbicide INP0341 for In Vivo Protection against a Vaginal Challenge by Chlamydia trachomatis.
Pedersen C, Slepenkin A, Andersson SB, Fagerberg JH, Bergström CA, Peterson EM. (2014)
PLoS One. Oct 30;9(10)
Relationships between the antidotal efficacy and structure, PK/PD parameters and bio-relevant molecular descriptors of AChE reactivating oximes: inclusion and integration to biopharmaceutical classification systems.
Voicu V, Radulescu FS, Medvedovici A. (2014)
Expert Opin Drug Metab Toxicol. 2015 Jan;11(1):95-109
Three-Dimensional Quantitative Structure-Activity Relationship Analysis for Human Pregnane X Receptor for the Prediction of CYP3A4 Induction in Human Hepatocytes: Structure-Based Comparative Molecular Field Analysis.
Handa K, Nakagome I, Yamaotsu N, Gouda H, Hirono S. (2014)
J Pharm Sci. Nov 7
A combination of pharmacophore modeling, molecular docking, and virtual screening for P2Y12 receptor antagonists from Chinese herbs.
He Y, Jiang L, Yang Z, Qiao Y, Zhang YL. (2014)
Canadian J. Chem. Nov 18

Ranking the binding energies of p53 mutant activators and their ADMET properties.
Omar SI, Tuszynski J. (2014)
Chem Biol Drug Des. Nov 19.
Concomitant intake of alcohol may increase the absorption of poorly soluble drugs.
Fagerberg JH, Sjögren E, Bergström CAS. (2014)
Eur. J. Pharm. Sci. 67:12-20

Imidazole aldoximes effective in assisting butyrylcholinesterase catalysis of organophosphate detoxification.
Sit RK, Fokin VV, Amitai G, Sharpless KB, Taylor P, Radic Z. (2014)
J Med Chem. Feb 27;57(4):1378-89.
Improving genetic programming for the prediction of pharmacokinetic parameters.
Vanneschi L. (2014)
Memetic Computing Oct 26
A new in vitro system for evaluation of passive intestinal drug absorption: Establishment of a double artificial membrane permeation assay.
Kataoka M, Tsuneishi S, Maeda Y, Masaoka Y, Sakuma S, Yamashita S. (2014)
Eur J Pharm Biopharm. 2014 Nov;88(3):840-6
Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: A comparison with carbamazepine, oxcarbazepine and lacosamide.
Hebeisen S, Pires N, Loureiro AI, Bonifácio MJ, Palma N, Whyment A, Spanswick D, Soares-da-Silva P. (2014)
Neuropharmacology. Sep 19;89C:122-135
The Poorly Membrane Permeable Antipsychotic Drugs Amisulpride and Sulpiride Are Substrates of the Organic Cation Transporters from the SLC22 Family.
Dos Santos Pereira JN, Tadjerpisheh S, Abed MA, Saadatmand AR, Weksler B, Romero IA, Couraud PO, Brockmöller J, Tzvetkov MV. (2014)
AAPS J. 2014 Nov;16(6):1247-58
In Silico Prediction of Major Drug Clearance Pathways by Support Vector Machines with Feature-Selected Descriptors.
Toshimoto K, Wakayama N, Kusama M, Maeda K, Sugiyama Y, Akiyama Y. (2014)
Drug Metab Dispos. 2014 Nov;42(11):1811-9
Synthesis of a novel universal opioid receptor agonist with the 1,3,5-trioxazatriquinane skeleton and its pharmacologies.
Hirayamaa S, Wadaa N, Kurodaa N, Iwaia T, Yamaotsua N, Hironoa S, Fujiia H, Nagasea H. (2014)
Bioorganic Med. Chem. Lett. 2014 Aug 12
Discovery of furan-2-carbohydrazides as orally active glucagon receptor antagonists.
Hasegawa F, Niidome K, Migihashi C, Murata M, Negoro T, Matsumoto T, Kato K, Fujii A. (2014)
Bioorg Med Chem Lett. 2014 Sep 1;24(17):4266-70
The acute effects of daily nicotine intake on heart rate - A toxicokinetic and toxicodynamic modelling study.
Gajewska M, Worth A, Urani C, Briesen H, Schramm KW. (2014)
Regul Toxicol Pharmacol. 2014 Oct;70(1):312-24
Physiologically based pharmacokinetic modeling for assessing the clinical drug-drug interaction of alisporivir.
Xia B, Barve A, Heimbach T, Zhang T, Gu H, Wang L, Einolf H, Alexander N, Hanna I, Ke J, Mangold JB, He H, Sunkara G. (2014)
Eur J Pharm Sci. 2014 Oct 15;63:103-12
Maximum Entropy in Drug Discovery.
Tseng CY, Tuszynski J. (2014)
Entropy 16:3754-3768
Predicting when Biliary Excretion of Parent Drug is a Major Route of Elimination in Humans.
Hosey CM, Broccatelli F, Benet LZ. (2014)
AAPS J. 2014 Sep;16(5):1085-96
Computational Predictions of Glass-Forming Ability and Crystallization Tendency of Drug Molecules.
Alhalaweh A, Alzghoul A, Kaialy W, Mahlin D, Bergström CA. (2014)
Mol Pharm. 2014 Sep 2;11(9):3123-32
Synthesis and Antioxidant Activity Evaluation of New Compounds from Hydrazinecarbothioamide and 1,2,4-Triazole Class Containing Diarylsulfone and 2,4-Difluorophenyl Moieties.
Barbuceanu SF, Ilies DC, Saramet G, Uivarosi V, Draghici C, Radulescu V
Int. J. Mol. Sciences 2014 15:10908-10925
Comparison of in silico models for prediction of Daphnia magna acute toxicity.
Golbamaki A, Cassano A, Lombardo A, Moggio Y, Colafranceschi M, Benfenati E
SAR QSAR Environ Res. 2014 Jun 9:1-22.
Non-linear assessment of anticancer activity of 17-picolyl and 17-picolinylidene androstane derivatives - Chemometric guidelines for further syntheses.
Kovačević SZ, Podunavac-Kuzmanović SO, Jevrić LR, Djurendić EA, Ajduković JJ
Eur J Pharm Sci. 2014 Jun 11;62C:258-266.
A tutorial for analysing the cost-effectiveness of alternative methods for assessing chemical toxicity: the case of acute oral toxicity prediction.
Norlen H, Worth AP, Gabbert S
Altern Lab Anim. 2014 May;42(2):115-27.
Using beta binomials to estimate classification uncertainty for ensemble models
Robert D Clark, Wenkel Liang, Adam C Lee, Michael S Lawless, Robert Fraczkiewicz, Marvin Waldman
Journal of Cheminformatics 2014, 6:34
BU08073 a Buprenorphine Analog with Partial Agonist Activity at mu Receptors in vitro but Long-Lasting Opioid Antagonist Activity in vivo in Mice.
Khroyan TV, Wu J, Polgar WE, Cami-Kobeci G, Fotaki N, Husbands SM, Toll L
Br J Pharmacol. 2014 Jun 5.
N-(furan-2-ylmethyl)-N-methylprop-2-yn-1-amine (F2MPA): A Potential Cognitive Enhancer with MAO Inhibitor Properties.
Di Giovanni G, García I, Colangeli R, Pierucci M, Rivadulla ML, Soriano E, Chioua M, Della Corte L, Yáñez M, De Deurwaerdère P, Fall Y, Marco-Contelles J
CNS Neurosci Ther. 2014 Jul;20(7):633-40.
Synthesis and in silico studies of pyrrolidine sulfonamide based dipeptides as β-gluscosidase inhibitors
B. Santosh Kumara, A. Raghavendra Guru Prasadb, G. Madhuc, P. Raveendra Reddya, L.K. Ravindranatha
Annales Pharmaceutiques Françaises 2014 Mar. 27
Differential effects of methoxy group on the interaction of curcuminoids with two major ligand binding sites of human serum albumin.
Sato H, Chuang VT, Yamasaki K, Yamaotsu N, Watanabe H, Nagumo K, Anraku M, Kadowaki D, Ishima Y, Hirono S, Otagiri M, Maruyama T
PLoS One. 2014 Feb 3;9(2):e87919.
Lipophilicity indices derived from the liquid chromatographic beVictor Voicua,
Victor Voicu, Costel Sârbu, Florentin Tache, Florina Micăle, Ştefan Flavian Rădulescu, Koichi Sakurada, Hikoto Ohta, Andrei Medvedovici
Talanta 2014 122:172-179
Metabolism and physiologically based pharmacokinetic modeling of flumioxazin in pregnant animals.
Takaku T, Nagahori H, Sogame Y
Toxicol Appl Pharmacol. 2014 Jun 15;277(3):242-9.

2013

Is the full potential of the biopharmaceutics classification system reached?
Bergstrom CA1, Andersson SB, Fagerberg JH, Ragnarsson G, Lindahl A
Eur J Pharm Sci. 2013 Sep 25.
In Silico Prediction of Ionization
R. Fraczkiewicz
"Reference Module in Chemistry, Molecular Sciences and Chemical Engineering." Ed. Reedijk J., Elsevier, 2013
Purely in Silico BCS Classification: Science Based Quality Standards for the World's Drugs
Dahan A, Wolk O, Kim YH, Ramachandran C, Crippen GM, Takagi T, Bermejo M, Amidon GL
Mol Pharm. 2013 Nov 4;10(11):4378-90.
Diaromatic sulphur-containing ‘naphthenic’ acids in process waters
Westa CE, Scarlett AG, Tonkina A, O’Carroll-Fitzpatricka D, Pureveenb J, Tegelaarb E, Gieleciak R, Hagerc D, Petersene K, Tollefsene KE, Rowlanda SJ
Water Research 2013 Nov. 1
3D QSAR and pharmacophore study of curcuminoids and curcumin analogs: interaction with thioredoxin reductase
Singh DV, Agarwal S, Kesharwani RK, Misra K
Interdiscip Sci. 2013 Dec;5(4):286-95.
Interaction of Silymarin Flavonolignans with Organic Anion Transporting Polypeptides (OATPs)
Kock K, Xie1 Y, Oberlies NH, Hawke RL, Brouwer KL
Drug Metab. Dispos. 2013 Feb. 11
In silico modeling to predict drug-induced phospholipidosis
Sydney S. Choi, Jae S. Kim, Luis G. Valerio Jr., Nakissa Sadrieh
Toxicol. Appl. Pharmacol. 2013
Interactions of laulimalide, peloruside, and their derivatives with the isoforms of s-tubulin
Gajewski MM, Tuszynski JA, Barakat K, Huzil JT, Klobukowskia M
Canadian J. Chem. 2013 Apr 2
Optimizing solubility and permeability of a biopharmaceutics classification system (BCS) class 4 antibiotic drug using lipophilic fragments disturbing the crystal lattice
Tehler U, Fagerberg JH, Svensson R, Larhed M, Artursson P, Bergstrom CA
J Med Chem. 2013 Mar 28;56(6):2690-4.
Three-Dimensional Quantitative Structure?Activity Relationship Analysis of Inhibitors of Human and Rat Cytochrome P4503A Enzymes
Koichi Handa, Izumi Nakagome, Noriyuki Yamaotsu, Hiroaki Gouda, Shuichi Hirono
Drug Metabolism and Pharmacokinetics
Interaction of Silymarin Flavonolignans with Organic Anion-Transporting Polypeptides
Kock K, Xie Y, Hawke RL, Oberlies NH, Brouwer KL
Drug Metab Dispos. 2013 May;41(5):958-65
Docking and in silico ADMET studies of noraristeromycin, curcumin and its derivatives with Plasmodium falciparum SAH hydrolase: A molecular drug target against malaria.
Singh DB, Gupta MK, Singh DV, Singh SK, Misra K
Interdiscip Sci. 2013 Mar;5(1):1-12.
A Computational Drug-Target Network for Yuanhu Zhitong Prescription
Haiyu Xu, Ye Tao, Peng Lu, Peng Wang, Fangbo Zhang, Yuan Yuan, Songsong Wang, Xuefeng Xiao, Hongjun Yang, Luqi Huang
Evidence-Based Complementary and Alternative Medicine Volume 2013
Oral delivery of anticancer drugs: challenges and opportunities
Thanki K, Gangwal RP, Sangamwar AT, Jain S
J Control Release. 2013 Aug 28;170(1):15-40.
Similarity-based virtual screening for microtubule stabilizers reveals novel antimitotic scaffold
Ayouba AT, Klobukowskia M, Tuszynski J
J. of Mol. Graphics and Model. 2013 June 25
Evaluation and optimisation of current milrinone prescribing for the treatment and prevention of low cardiac output syndrome in paediatric patients after open heart surgery using a physiology-based pharmacokinetic drug-disease model
Vogt W
Clin Pharmacokinet. 2014 Jan;53(1):51-72.
Dendritic Cell Immunoreceptor Is a New Target for Anti-AIDS Drug Development: Identification of DCIR/HIV-1 Inhibitors.
Lambert AA, Azzi A, Lin SX, Allaire G, St-Gelais KP, Tremblay MJ, Gilbert C
PLOS ONE 2013
Validation of quantitative structure-activity relationship models to predict water-solubility of organic compounds
Cappelli CI, Manganelli S, Lombardo A, Gissi A, Benfenati E
Science of the Total Environment 2013 463-64:781-89

2012

Computational Prediction of Metabolism: Sites, Products, SAR, P450 Enzyme Dynamics, and Mechanisms
Johannes Kirchmair, Mark J. Williamson, Jonathan D. Tyzack, Lu Tan, Peter J. Bond, Andreas Bender, and Robert C. Glen
J. Chem. Inf. Model., 2012, 52 (3), pp 617-648
Provisional Biopharmaceutical Classification of Some Common Herbs Used in Western Medicine.
Waldmann S, Almukainzi M, Chacra NB, Amidon GL, Lee BJ, Feng J, Kanfer I, Zuo JZ, Wei H, Bolger MB, Lobenberg R.
Mol. Pharm., 2012, Feb. 18
Parameters for pyrethroid insecticide QSAR and PBPK/PD models for human risk assessment.
Knaak JB, Dary CC, Zhang X, Gerlach RW, Tornero-Velez R, Chang DT, Goldsmith R, Blancato JN.
Rev. Environ. Contam. Toxicol., 2012, 219:1-114
Classification of Inhibitors of Hepatic Organic Anion Transporting Polypeptides (OATPs): Influence of Protein Expression on Drug- Drug Interactions.
Karlgren M, Vildhede A, Norinder U, Wisniewski JR, Kimoto E, Lai Y, Haglund U, Artursson P.
J. Med. Chem., 2012, 55(10):4740-63
Ethanol Effects on Apparent Solubility of Poorly Soluble Drugs in Simulated Intestinal Fluid.
Fagerberg JH, Al-Tikriti Y, Ragnarsson G, Bergstrom CA.
Mol. Pharm., 2012, June 20
Computational Prediction of CNS Drug Exposure Based on a Novel In Vivo Dataset
Bergstrom CAS, Charman SA, Nicolazzo JA.
Pharm. Res., 2012, 29(11):3131-42
Dynamic Change of Heme Environment in Soluble Guanylate Cyclase and Complexation of NO-Independent Drug Agents with H-NOX Domain.
Alisaraie L, Fu Y, A Tuszynski J.
Chem Biol Drug Des., 2012, Oct. 24
Toxicological considerations of acetylcholinesterase reactivators.
Voicu V, Radulescu FS, Medvedovici A.
Expert Opinion Drug Metab. and Toxicol., 2012, Nov. 24
Integrated Pharmacokinetic-Driven Approach to Screen Candidate Anticancer Drugs for Brain Tumor Chemotherapy.
Lv H, Zhang X, Sharma J, Reddy MVR, Reddy EP, Gallo JM.
AAPS J., 2012, Nov. 22
Nilotinib preclinical pharmacokinetics and practical application toward clinical projections of oral absorption and systemic availability
Xia, B., Heimbach, T., He, H., and Lin, T.-h.
Biopharmaceutics & Drug Disposition, web edition, 2012
Simulation of the pharmacokinetics of bisoprolol in healthy adults and patients with impaired renal function using whole-body physiologically based pharmacokinetic modeling
Li, G.-f., Wang, K., Chen, R., Zhao, H.-r., Yang, J., and Zheng, Q.-s.
Acta Pharmacol. Sin., 2012, 33: 1359-1371
Virtual Screening and Biological Evaluation of Inhibitors Targeting the XPA-ERCC1 Interaction.
Barakat KH, Jordheim LP, Perez-Pineiro R, Wishart D, Dumontet C, Tuszynski JA.
PLoS ONE, 2012, 7(12): e51329
In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug?Drug Interactions
Karlgren M, Ahlin G, Bergstrom CAS, Svensson R, Palm J, Artursson P.
Pharm. Res., 2012, 29:2, 411-426

2011

A Model-Based Prioritisation Exercise for the European Water Framework Directive
Klaus Daginnus, Stefania Gottardo, Ana Paya-Perez, Paul Whitehouse, Helen Wilkinson, Jose-Manuel Zaldivar
Int J Environ Res Public Health. 2011 February; 8(2): 435?455
Tumor Physiology and Charge Dynamics of Anticancer Drugs: Implications for Camptothecin-based Drug Development
D.J. Adams, L.R. Morgan
Curr Med Chem. 2011; 18(9): 1367?1372
Inhibition of Dengue Virus through Suppression of Host Pyrimidine Biosynthesis
Qing-Yin Wang, Simon Bushell, Min Qing, Hao Ying Xu, Aurelio Bonavia, Sandra Nunes, Jing Zhou, Mee Kian Poh, Paola Florez de Sessions, Pornwaratt Niyomrattanakit, Hongping Dong, Keith Hoffmaster, Anne Goh, Shahul Nilar, Wouter Schul, Susan Jones, Laura Kramer, Teresa Compton, Pei-Yong Shi
J Virol. 2011 July; 85(13): 6548?6556
Software and resources for computational medicinal chemistry
Chenzhong Liao, Markus Sitzmann, Angelo Pugliese, Marc C Nicklaus
Future Med Chem. 2011 June; 3(8): 1057?1085
Automated Information Extraction and Structure?Activity Relationship Analysis of Cytochrome P450 Substrates
Fumiyoshi Yamashita, Chunlai Feng, Shuya Yoshida, Takayuki Itoh, and Mitsuru Hashida
J. Chem. Inf. Model., 2011, 51 (2), pp 378-385
Novel ADMET design tool for chemists
DW Miller, R Fraczkiewicz, WS Woltosz
Journal of Cheminformatics, 2011, 3(Suppl 1):P9
Use of structure-activity landscape index curves and curve integrals to evaluate the performance of multiple machine learning prediction models
LeDonne Jr NC, Rissolo K, Bulgarelli J, Tini L.
J. Cheminformatics, 2011, 3:7
Quantitative Prediction of Regioselectivity Toward Cytochrome P450/3A4 Using Machine Learning Approaches
Hasegawa K, Koyama M, Funatsu K
Mol. Inf., 2011, 29, 243-249

2010

In Silico Classification of Major Clearance Pathways of Drugs with Their Physiochemical Parameters
Kusama M, Toshimoto K, Maeda K, Hirai Y, Imai S, Chiba K, Akiyama Y, Sugiyama Y.
Drug Metab Dispos., 2010, 38, 1362-1370
irtual screening using ligand-based pharmacophores for inhibitors of human tyrosyl-DNA phospodiesterase (hTdp1)
Iwona E. Weidlich, Thomas S. Dexheimer, Christophe Marchand, Smitha Antony, Yves Pommier, Marc C. Nicklaus
Bioorganic & Medicinal Chemistry, Volume 18, Issue 6, 15 March 2010, Pages 2347-2355
Characterization of Dengue Virus Resistance to Brequinar in Cell Culture
Min Qing, Gang Zou, Qing-Yin Wang, Hao Ying Xu, Hongping Dong, Zhiming Yuan, Pei-Yong Shi
Antimicrob Agents Chemother. 2010 September; 54(9): 3686?3695
Pharmacokinetic/Pharmacodynamic-Driven Drug Development
James M. Gallo
Mt Sinai J Med. 2010 Jul-Aug; 77(4): 381?388

2009

Practical Anticipation of Human Efficacious Doses and Pharmacokinetics Using In Vitro and Preclinical In Vivo Data
Tycho Heimbach, Suresh B. Lakshminarayana, Wenyu Hu, Handan He
AAPS J. 2009 September; 11(3): 602?614
Busting the Black Box Myth: Designing Out Unwanted ADMET Properties with Machine Learning Approaches.
Fraczkiewicz R, Zhuang D, Zhang J, Miller D, Woltosz WS, Bolger MB.
CICSJ Bulletin, 2009, 27(4): 96-102
Optimizing the Performance of In Silico ADMET General Models According to Local Requirements: MARS Approach. Solubility Estimations As Case Study.
Oyarzabal J, Pastor J, Howe TJ.
J. Chem. Inf. Model., 2009, 49 (12), 2837-2850
In Silico Prediction of Aqueous Solubility: The Solubility Challenge.
Hewitt M, Cronin MT, Enoch SJ, Madden JC, Roberts DW, Dearden JC.
J. Chem. Inf. Model., 2009, 49(11), 2572?2587
Predicting pKa.
Lee AC, Crippen GM.
J. Chem. Inf. Model., 2009, Sep;49(9):2013-33
Analysis of Risk Factors in Human Bioequivalence Study That Incur Bioinequivalence of Oral Drug Products.
Yamashita S, Tachiki H.
Mol. Pharm., 2009, 6(1), 48-59
Toward an In Vivo Dissolution Methodology: A Comparison of Phosphate and Bicarbonate Buffers.
Sheng JJ, McNamara DP, Amidon GL.
Mol. Pharm., 2009, 6(1), 29-39

2008

Structural Requirements for Drug Inhibition of the Liver Specific Human Organic Cation Transport Protein 1.
Ahlin G, Karlsson J, Pedersen JM, Gustavsson L, Larsson R, Matsson P, Norinder U, Bergstrom CAS, Artursson P.
J. Med. Chem., 2008, 51(19), 5932-5942
Calculation of molecular lipophilicity: State-of-the-art and comparison of log P methods on more than 96,000 compounds.
Mannhold R, Poda GI, Ostermann C, Tetko IV.
J. Pharm. Sci., 2008, 98(3):861-93
Novel Hierarchical Classification and Visualization Method for Multiobjective Optimization of Drug Properties: Application to Structure-Activity Relationship Analysis of Cytochrome P450 Metabolism
Yamashita F, Hara H, Ito T, Hashida M.
J. Chem. Inf. Model., 2008, 48, 364-369

2007

The prediction of drug metabolism, tissue distribution, and bioavailability of 50 structurally diverse compounds in rat using mechanism-based absorption, distribution, and metabolism prediction tools.
De Buck SS, Sinha VK, Fenu LA, Gilissen RA, Mackie CE, Nijsen MJ.
Drug Metab Dispos., 2007, 35(4):649-59
Property-based logP prediction.
Tetko IV, and Poda GI. In: R. Mannhold (ed.),
"Molecular Drug Properties: Measurement and Prediction", Chapter 15. Weinheim, Germany: Wiley-VCH; 2007
Targeting Plague Virulence Factors: A Combined Machine Learning Method and Multiple Conformational Virtual Screening for the Discovery of Yersinia Protein Kinase A Inhibitors.
Hu X, Prehna G, Stebbins CE.
J. Med. Chem., 2007, 50(17), 3980-3983

2006

Visualization of Large-Scale Aqueous Solubility Data Using a Novel Hierarchical Data Visualization Technique
Fumiyoshi Yamashita, Takayuki Itoh, Hideto Hara, and Mitsuru Hashida
J. Chem. Inf. Model., 2006, 46 (3), pp 1054-1059
Levels and Concentration Ratios of Polychlorinated Biphenyls and Polybrominated Diphenyl Ethers in Serum and Breast Milk in Japanese Mothers
Kayoko Inoue, Kouji Harada, Katsunobu Takenaka, Shigeki Uehara, Makoto Kono, Takashi Shimizu, Takumi Takasuga, Kurunthachalam Senthilkumar, Fumiyoshi Yamashita, Akio Koizumi
Environ Health Perspect. 2006 August; 114(8): 1179?1185
In silico prediction of ionization.
Fraczkiewicz R. In: B. Testa and H. van de Waterbeemd (eds.),
Comprehensive Medicinal Chemistry II, Vol. 5, pp. 603-26. Oxford, UK: Elsevier; 2006
In silico prediction of aqueous solubility.
Dearden JC.
Expert Opin. Drug Discov., 2006, 1:31-52

2003

A comparison of commercially available software for the prediction of partition coefficient.
Dearden JC, Netzeva TI, Bibby R.
In: EuroQSAR 2002: "Designing Drugs and Crop Protectants: Processes, Problems and Solutions", Bournemouth, UK, 8-13 September 2003, pp. 168-69
Correlation between the physicochemical property of some nonsteroidal anti-inflammatory drugs and changes in adenosine triphosphate, glutathione and hemoglobin in rat erythrocytes.
Shimizu M, Tatsuno M, Matsushita R, Totsuka J, Inoue Y, Ohta K, Kuniya K, Fujii N, Fukasawa Y, Watanabe N, Iwata E, Miyazaki M, Hoshino M, Onda M, Matsumura M, Kikuchi Y, Yamamoto C, Hamada M, Tsuyuki A, Furuta T, Kadokura C, Kamiyama Y, Kitahara G, Suzuki K, Sejima E, Matsumoto Y, Fukuoka M.
Biol. Pharm. Bull., 2003, 26(8), 1155-65
SSL

©2004-2024 Northern Science Consulting Inc. All Rights Reserved.